KdT Ventures

Equii is a food technology company that discovers highly nutritious sources of microbial proteins that are used to ferment grains and produce high-protein grain flours. Founded in 2021 by Monica Bhatia, Equii is based in San Ramon, California.

Tavros Therapeutics is a biotechnology company founded in 2019 and based in Durham, North Carolina. The company focuses on discovering and developing therapies for cancer, aiming to improve oncological treatment outcomes. Tavros Therapeutics is dedicated to identifying vulnerabilities within tumors, which allows for the targeted application of specific drugs in conjunction with optimal combinations. This approach is intended to enhance the effectiveness of cancer treatments and increase the potential for patient cures.

Canaery is building a neural interface for analyzing an object’s scent fingerprint to identify dangerous compounds at places like ports and inspection points without (or in addition to) x-rays or cameras.

Unravel Biosciences develops a vertically integrated computational platform to improve drug discovery. Unravel’s platform screens many drugs in parallel for their real-world impact (e.g., the complete gene expression profiles and resulting physiological changes), reversing this process to identify the likely target(s) a drug is interacting with.

Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.

Marigold Health operates a social network community platform designed to provide text-based group therapies for individuals facing mental health and substance use challenges. The platform facilitates anonymous chat support groups, allowing patients to connect with peers and receive assistance from coaches who have personal recovery experience. This approach not only fosters a stigma-free environment for recovery but also enhances patient engagement in community-based treatment. By partnering with treatment providers and managed care organizations within the Medicaid market, Marigold Health effectively augments traditional care models, enabling care teams to increase their capacity while delivering personalized support to patients.

Faeth Therapeutics is a healthcare company dedicated to enhancing cancer treatment through a deep understanding of the relationship between dietary nutrients and tumor growth. By aligning specific diets with tumor genotypes and treatment regimens, Faeth aims to limit the energy and resources that tumors need to proliferate, thereby improving patient outcomes in cancer therapy. Founded by leading researchers and clinicians, the company seeks to translate significant discoveries from cancer research laboratories into effective clinical practices, focusing on evidence-based approaches to optimize treatment strategies for cancer patients.

Greeneye Technology specializes in precision agriculture by developing advanced solutions that automate field scouting and optimize herbicide application. Founded in 2016 and based in Canada, the company harnesses artificial intelligence and machine learning to transform traditional pest control methods. Its proprietary selective spraying system allows for precise real-time detection and targeting of weeds, significantly reducing herbicide usage by up to 90%. By integrating its technology with existing sprayers, Greeneye enables farmers to minimize waste and improve the efficiency of their pest control practices. The company boasts a multidisciplinary team with expertise in various fields, including computer vision, agronomy, and mechanical engineering, all dedicated to providing sustainable agricultural solutions.

ZymoChem, Inc. develops microbes and bioprocesses that enable production of chemicals from renewable sources, such as sugars. The company was founded in 2013 and is based in Emeryville, California.

Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME). The interplay between cancer cells and their surrounding microenvironment is relevant in drug development as manycancers use the TME to build barriers that shield immune system attack. One approach, PRTH-101, breaks these barriers to overcome recalcitrant cancers. Based on research, the company is designing a portfolio of drug candidates to treat the right patients at the right time.

54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Andes Ag, Inc., founded in 2018 and headquartered in San Francisco, California, specializes in developing microbe-based seed technologies aimed at promoting sustainable agriculture. The company leverages beneficial microbes that have naturally co-evolved with plants over millennia. Through scientific research and advanced predictive software powered by artificial intelligence, Andes creates customized microbe-based formulations designed to enhance crop yields, accelerate growth, and enable cultivation in traditionally unsuitable lands. These solutions also aim to reduce the reliance on fertilizers and pesticides, helping farmers address the challenges posed by global climate change. Andes is positioned to contribute significantly to a new green revolution, fostering responsible and environmentally friendly agricultural practices.

Modulus Therapeutics is an artificial-intelligence-powered cell therapy design company.

Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Dyno Therapeutics Inc. specializes in the development of adeno-associated virus (AAV) vectors for in vivo delivery of gene therapies. Founded in 2018 and based in Cambridge, Massachusetts, the company utilizes an artificial intelligence-driven approach that integrates DNA synthesis, sequencing, and machine learning. This innovative methodology enables the design of novel gene vectors with an emphasis on cell-targeting capsid proteins derived from AAV, which is recognized as the most commonly used vector in gene therapy applications. By leveraging quantitative high-throughput in vivo experimentation, Dyno Therapeutics aims to enhance the effectiveness and precision of gene therapy solutions.

SeQure DX is in the business activities at non-commercial site business. It was founded in 2020 and is based in Waltham, Massachusetts.

Theator is a technology company that focuses on enhancing surgical performance through its artificial intelligence-driven video platform, known as Minutes. Established in 2018, Theator operates from Tel Aviv, Israel, and has a presence in California. The platform utilizes a comprehensive dataset to provide surgeons with tools for content management and visual operative reporting, complete with analytics. By analyzing video data from surgical procedures, Minutes enables surgeons to evaluate their performance, review past cases, and prepare for future surgeries, thereby fostering continuous skill development. Theator aims to improve surgical outcomes and promote a more transparent operating room environment by partnering with surgeons and healthcare institutions to advance surgical intelligence and decision-support systems.

Onc AI, founded in 2020 and based in San Carlos, California, specializes in clinical oncology and offers a precision oncology clinical management platform. The company focuses on enhancing decision-making in cancer care through a comprehensive approach that encompasses genomics, proteomics, and radiomics. By leveraging deep learning technologies, Onc AI aims to provide actionable insights that empower healthcare providers in the effective treatment of cancer.

Dimension Inx Corp. is a Chicago-based company specializing in the design and development of advanced biomaterials and 3D-printed implants for medical applications. Established in 2016, the company focuses on creating innovative solutions that address human disease and tissue regeneration. Its product offerings include Hyperelastic Bone, a 3D printable material intended for bone regeneration, and Fluffy-X, a solution designed for soft tissue regeneration. Dimension Inx also provides 3D printable elastomers and bioactive ceramics, as well as commercial medical devices. By leveraging additive manufacturing and bio-fabrication processes, the company aims to enhance the versatility, manufacturability, and affordability of regenerative medical products, ultimately enabling clinicians to improve patient outcomes and reduce dependence on organ transplantation.

Andes Ag, Inc., founded in 2018 and headquartered in San Francisco, California, specializes in developing microbe-based seed technologies aimed at promoting sustainable agriculture. The company leverages beneficial microbes that have naturally co-evolved with plants over millennia. Through scientific research and advanced predictive software powered by artificial intelligence, Andes creates customized microbe-based formulations designed to enhance crop yields, accelerate growth, and enable cultivation in traditionally unsuitable lands. These solutions also aim to reduce the reliance on fertilizers and pesticides, helping farmers address the challenges posed by global climate change. Andes is positioned to contribute significantly to a new green revolution, fostering responsible and environmentally friendly agricultural practices.

Abridge AI Inc. is a developer of a healthcare mobile application that focuses on enhancing understanding during medical conversations. Founded in 2018 and headquartered in Pittsburgh, Pennsylvania, Abridge's application utilizes machine learning to record and summarize audio from medical discussions, helping users identify diagnoses, medications, and treatments. This technology aims to provide clarity and context, enabling individuals to better follow through with healthcare recommendations and stay informed about their health. By highlighting essential medical terms, Abridge empowers users to actively engage in their healthcare journeys, whether in clinical settings or at home.

Abridge AI Inc. is a developer of a healthcare mobile application that focuses on enhancing understanding during medical conversations. Founded in 2018 and headquartered in Pittsburgh, Pennsylvania, Abridge's application utilizes machine learning to record and summarize audio from medical discussions, helping users identify diagnoses, medications, and treatments. This technology aims to provide clarity and context, enabling individuals to better follow through with healthcare recommendations and stay informed about their health. By highlighting essential medical terms, Abridge empowers users to actively engage in their healthcare journeys, whether in clinical settings or at home.

Rarebird, founded in 2020 and based in Oakland, California, specializes in producing a coffee alternative that replaces traditional caffeine. The company offers Paraxanthine coffee, a beverage designed to enhance alertness without the negative side effects commonly associated with caffeine, such as jitters and anxiety. This innovative product aims to cater to individuals who are sensitive to caffeine while providing a suitable option for those seeking increased focus and energy. Rarebird is committed to transforming the coffee experience by introducing a healthier alternative to conventional caffeinated beverages.

Andes Ag, Inc., founded in 2018 and headquartered in San Francisco, California, specializes in developing microbe-based seed technologies aimed at promoting sustainable agriculture. The company leverages beneficial microbes that have naturally co-evolved with plants over millennia. Through scientific research and advanced predictive software powered by artificial intelligence, Andes creates customized microbe-based formulations designed to enhance crop yields, accelerate growth, and enable cultivation in traditionally unsuitable lands. These solutions also aim to reduce the reliance on fertilizers and pesticides, helping farmers address the challenges posed by global climate change. Andes is positioned to contribute significantly to a new green revolution, fostering responsible and environmentally friendly agricultural practices.

Xilis, Inc. is an oncology and precision health company that focuses on improving cancer diagnosis and treatment. Founded in 2019 and based in Chapel Hill, North Carolina, Xilis utilizes advanced organoid technologies, specifically micro-organoids, to create thousands of 3D replicas of a patient's tumor within six days. This innovative approach allows for rapid diagnostics and personalized drug screening, enabling healthcare providers to identify the most effective treatments for individual patients. The company's platform supports scalable, patient-derived models that facilitate high-throughput drug discovery, ultimately assisting physicians and pharmaceutical companies in developing tailored therapies at a reduced cost.

54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.

Circularis Biotechnologies, Inc. is a biotechnology company established in 2014 and based in California. The company focuses on developing innovative methods to regulate gene expression, aiming to enhance the production yields of biotherapeutics. Circularis offers a range of products, including RACRE Variant Libraries, hCMV Variant Library, and T7 Variant Library, as well as services such as RACRE Enhancement, RACRE Discovery, RACRE Technology Access Program, and Ribozyme Analysis of Cis-Regulatory Elements. By improving the targeting of gene therapy and optimizing gene expression in under-researched organisms, Circularis seeks to advance the fields of gene therapy, biomanufacturing, and synthetic biology, ultimately benefiting medical practitioners and enhancing therapeutic outcomes.

Biopharmaceutical research and development company that's an affiliate of Clover Health

Debut Biotechnology, Inc. is a biotechnology company based in San Diego, California, established in 2019. It specializes in biomanufacturing solutions for high-value molecules, focusing on the development of specialty enzyme solutions and continuous manufacturing processes. The company offers a range of services, including biomanufacturing cartridges, fermentation, and the immobilization of cells and enzymes. Debut Biotechnology is dedicated to creating novel immobilization techniques for enzymes, achieving high success rates and providing immobilized enzymes for continuous manufacturing systems. Its innovative approach enables the production and modification of small and large molecules, catering primarily to the pharmaceutical and specialty chemical industries. By harnessing natural enzyme technologies, Debut aims to deliver sustainable and cost-effective ingredient solutions to its clients.

Azitra Inc. is a clinical-stage medical dermatology company based in Farmington, Connecticut, focused on developing microbiome-based therapeutics for skin diseases. Established in 2014, Azitra leverages its proprietary platform, which includes a microbial library of bacterial strains, to discover and create novel treatments for adverse skin conditions. The company's technology, developed in collaboration with researchers at Yale University and the Jackson Laboratory, is centered around a specific strain of the natural commensal bacteria Staphylococcus epidermidis. Additionally, Azitra employs artificial intelligence and machine learning to enhance the screening and prediction of therapeutic characteristics within its microbial library. By utilizing engineered proteins and live biotherapeutic products for topical application, Azitra aims to advance precision dermatology.

54gene develops a pan-African biobank to identify new drug targets, and develop diagnostics and treatments for diseases. The company targets multiple disease states, including cancer, cardiovascular disease, and neuro-degenerative disease. It also provides genetic testing and molecular diagnostics services. The company was founded in 2019 and is based in San Francisco, California with an additional offices in Lagos, Nigeria.

Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.

Theator is a technology company that focuses on enhancing surgical performance through its artificial intelligence-driven video platform, known as Minutes. Established in 2018, Theator operates from Tel Aviv, Israel, and has a presence in California. The platform utilizes a comprehensive dataset to provide surgeons with tools for content management and visual operative reporting, complete with analytics. By analyzing video data from surgical procedures, Minutes enables surgeons to evaluate their performance, review past cases, and prepare for future surgeries, thereby fostering continuous skill development. Theator aims to improve surgical outcomes and promote a more transparent operating room environment by partnering with surgeons and healthcare institutions to advance surgical intelligence and decision-support systems.

Checkerspot, Inc. is a biotechnology company based in Berkeley, California, founded in 2016. The company specializes in producing performance materials derived from microalgae, leveraging advancements in biology, chemistry, and materials science. Checkerspot's innovative technology platform enables the design of new materials at the molecular level, allowing for the creation of tailored solutions for various industrial applications. By integrating molecular foundry techniques with fermentation processes, the company develops sustainable materials, including polyurethanes and textile finishes, that meet the specific needs of product designers. Checkerspot collaborates closely with product users and socially responsible corporations to prototype and iterate on products, ultimately bringing superior materials to market that promote sustainability and enhanced performance.

Terray Therapeutics, Inc. operates as a biotechnology company. The company develops treatments for intractable cause of human diseases. It engages in development of a screening platform for drug discovery and Platinum Technology, which is working on an electrode-like product for deep brain stimulation. The company was founded in 2018 and is based in Pasadena, California.

Abridge AI Inc. is a developer of a healthcare mobile application that focuses on enhancing understanding during medical conversations. Founded in 2018 and headquartered in Pittsburgh, Pennsylvania, Abridge's application utilizes machine learning to record and summarize audio from medical discussions, helping users identify diagnoses, medications, and treatments. This technology aims to provide clarity and context, enabling individuals to better follow through with healthcare recommendations and stay informed about their health. By highlighting essential medical terms, Abridge empowers users to actively engage in their healthcare journeys, whether in clinical settings or at home.

Hi Fidelity Genetics LLC is a startup based in Durham, North Carolina, specializing in the development of hardware and software for plant-breeding applications. The company provides tools designed to measure and predict various plant traits, which are essential for ensuring a stable food supply in the face of a growing global population and changing climate conditions.

Abridge AI Inc. is a developer of a healthcare mobile application that focuses on enhancing understanding during medical conversations. Founded in 2018 and headquartered in Pittsburgh, Pennsylvania, Abridge's application utilizes machine learning to record and summarize audio from medical discussions, helping users identify diagnoses, medications, and treatments. This technology aims to provide clarity and context, enabling individuals to better follow through with healthcare recommendations and stay informed about their health. By highlighting essential medical terms, Abridge empowers users to actively engage in their healthcare journeys, whether in clinical settings or at home.

Dyno Therapeutics Inc. specializes in the development of adeno-associated virus (AAV) vectors for in vivo delivery of gene therapies. Founded in 2018 and based in Cambridge, Massachusetts, the company utilizes an artificial intelligence-driven approach that integrates DNA synthesis, sequencing, and machine learning. This innovative methodology enables the design of novel gene vectors with an emphasis on cell-targeting capsid proteins derived from AAV, which is recognized as the most commonly used vector in gene therapy applications. By leveraging quantitative high-throughput in vivo experimentation, Dyno Therapeutics aims to enhance the effectiveness and precision of gene therapy solutions.

Tierra Biosciences is a biotechnology company that specializes in developing cell-free technologies to facilitate the discovery of challenging molecules that traditional laboratory cell methods struggle to produce. Utilizing automation, computation, and high-throughput cell-free expression techniques, the company enables the expression of DNA from various microbial sources. Its Next Generation Expression platform enhances bio-discovery by allowing for rapid and experimentally validated data collection. Founded in 2015 and originally named Synvitrobio, the company rebranded to Tierra Biosciences in September 2018. It is headquartered in San Francisco, California.

Tierra Biosciences is a biotechnology company that specializes in developing cell-free technologies to facilitate the discovery of challenging molecules that traditional laboratory cell methods struggle to produce. Utilizing automation, computation, and high-throughput cell-free expression techniques, the company enables the expression of DNA from various microbial sources. Its Next Generation Expression platform enhances bio-discovery by allowing for rapid and experimentally validated data collection. Founded in 2015 and originally named Synvitrobio, the company rebranded to Tierra Biosciences in September 2018. It is headquartered in San Francisco, California.

Visla Labs Inc. is a San Francisco-based company that specializes in developing an artificial intelligence platform tailored for the radiology and healthcare sectors. Founded in 2018, the company focuses on enhancing medical diagnostics through advanced AI technologies, aiming to improve the efficiency and accuracy of radiological assessments.

Checkerspot, Inc. is a biotechnology company based in Berkeley, California, founded in 2016. The company specializes in producing performance materials derived from microalgae, leveraging advancements in biology, chemistry, and materials science. Checkerspot's innovative technology platform enables the design of new materials at the molecular level, allowing for the creation of tailored solutions for various industrial applications. By integrating molecular foundry techniques with fermentation processes, the company develops sustainable materials, including polyurethanes and textile finishes, that meet the specific needs of product designers. Checkerspot collaborates closely with product users and socially responsible corporations to prototype and iterate on products, ultimately bringing superior materials to market that promote sustainability and enhanced performance.

Rejuvenate Bio Inc is a biotechnology company based in Brookline, Massachusetts, founded in 2017. The company specializes in developing gene therapies aimed at enhancing the health and longevity of domesticated animals, particularly dogs. Rejuvenate Bio offers anti-aging treatments by introducing new DNA instructions into the animals' bodies. Additionally, the company provides gene therapies designed to target and cure specific diseases in pets, contributing to improved overall well-being and lifespan.

Patchd Inc is a healthcare technology company based in San Francisco, California, founded in 2017. The company specializes in developing a wearable device designed to predict sepsis in outpatient settings. Its wireless patch continuously collects vital sign data, enabling healthcare providers to monitor patients effectively. By employing artificial intelligence algorithms, Patchd's technology facilitates the early detection of life-threatening conditions, particularly when used by hospitals for newly admitted patients. This innovative approach aims to enhance patient care and improve outcomes in post-acute care scenarios.

Azitra Inc. is a clinical-stage medical dermatology company based in Farmington, Connecticut, focused on developing microbiome-based therapeutics for skin diseases. Established in 2014, Azitra leverages its proprietary platform, which includes a microbial library of bacterial strains, to discover and create novel treatments for adverse skin conditions. The company's technology, developed in collaboration with researchers at Yale University and the Jackson Laboratory, is centered around a specific strain of the natural commensal bacteria Staphylococcus epidermidis. Additionally, Azitra employs artificial intelligence and machine learning to enhance the screening and prediction of therapeutic characteristics within its microbial library. By utilizing engineered proteins and live biotherapeutic products for topical application, Azitra aims to advance precision dermatology.

Elemental Machines, Inc. is a technology company based in Cambridge, Massachusetts, founded in 2014. The company focuses on enhancing laboratory operations in science-based industries through its smart lab platform, which delivers data-driven insights. By continuously monitoring equipment and environmental variables, Elemental Machines aims to improve clarity, transparency, and consistency in research, development, and manufacturing processes. This approach not only enhances repeatability but also enables the collection of new data sets for advanced analytics, ultimately revolutionizing the efficiency and effectiveness of laboratory operations.

Elemental Machines, Inc. is a technology company based in Cambridge, Massachusetts, founded in 2014. The company focuses on enhancing laboratory operations in science-based industries through its smart lab platform, which delivers data-driven insights. By continuously monitoring equipment and environmental variables, Elemental Machines aims to improve clarity, transparency, and consistency in research, development, and manufacturing processes. This approach not only enhances repeatability but also enables the collection of new data sets for advanced analytics, ultimately revolutionizing the efficiency and effectiveness of laboratory operations.

Hi Fidelity Genetics LLC is a startup based in Durham, North Carolina, specializing in the development of hardware and software for plant-breeding applications. The company provides tools designed to measure and predict various plant traits, which are essential for ensuring a stable food supply in the face of a growing global population and changing climate conditions.

PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Solugen, Inc. is a specialty chemicals manufacturer based in Houston, Texas, founded in 2016. The company utilizes industrial biotechnology and green chemistry to produce a range of eco-friendly industrial chemicals. Its product offerings include BioPeroxide, a carbon-negative hydrogen peroxide; BioChelate, a biodegradable chelant; ScavSol, a multivalent metal sequestrant for energy applications; ScaleSol, a scale control alternative to phosphonates; and CorrSol, designed for corrosion and fouling control. Solugen focuses on creating safe, cost-effective, and environmentally-friendly solutions, serving various sectors such as agriculture, cleaning, energy, and water. The company employs a patented method that leverages bio-inspired reactions and plant materials as low-cost feedstocks, enabling it to produce innovative products that are competitively priced in the market.